Amgen

Regeneron presses Amgen for eylea antitrust damages evidence Bloomberg Law21:29Pharma Regeneron Biotech

Well-known genus, novel method: A post-Amgen framework for written description & enablement JD Supra21:57Patent Law Intellectual Property Pharma

Biocon launches denosumab biosimilars BOSAYA™ / AUKELSO™ in the United States JD Supra17:58Pharma Biotech

Amgen Inc. (AMGN) is a trending stock: Facts to know before betting on it Zacks15:09Pharma

FDA proposes to withdraw Amgen's drug for rare autoimmune diseases over effectiveness The Hindu Business Line05:34FDA Pharma Biotech

Az, Amgen will pilot FDA's real-time clinical trial plan pharmaphorum13:09FDA AstraZeneca Pharma

Amgen (AMGN) Q1 earnings and revenues beat estimates Zacks23:20Pharma Biotechnology

Amgen (AMGN) stock slides as market rises: Facts to know before you trade Zacks23:55Stock Markets (World) Stock Market (US) S&P 500

‘Winning it again is always a goal’ - Shane Lowry confirmed for Amgen Irish Open at Doonbeg The Irish Independent11:58Shane Lowry County Offaly County Louth

Shane Lowry confirms he will join Rory McIlroy at Amgen Irish Open The4213:36Shane Lowry Republic of Ireland Sport Pharma

Latest News

In the last 7 days

2 Dividend Stocks to Double Up On Right Now The Motley Fool18:51 8-May-26

Amgen To Present At The Bank Of America Merrill Lynch Global Healthcare Conference Amgen (Press Release)21:06 7-May-26

Shane Lowry confirms he will join Rory McIlroy at Amgen Irish Open The4213:36 6-May-26

Amgen invests additional $300m to strengthen biomanufacturing in Puerto Rico European Pharmaceutical Review12:17 6-May-26

‘Winning it again is always a goal’ - Shane Lowry confirmed for Amgen Irish Open at Doonbeg The Irish Independent11:58 6-May-26

Amgen Expands Puerto Rico Biologics Facility With Additional $300M Investment Amid Tariff Pressure Barchart01:11 5-May-26

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know Zacks15:00 4-May-26

Amgen Announces Additional $300 Million U.S. Manufacturing Investment, Totaling Nearly $2… PR Newswire (Press Release)14:03 4-May-26

In the last month

Did Amgen’s Raised 2026 Outlook and AI-Focused Overhaul Just Shift AMGN’s Investment Narrative? Simply Wall St11:03 3-May-26

IRS Seeks More Taxes From Amgen, Adding to $10.7 Billion Dispute Bloomberg Law16:31 1-May-26

Amgen (AMGN) Q1 Earnings and Revenues Beat Estimates Zacks23:20 30-Apr-26

Regeneron Presses Amgen for Eylea Antitrust Damages Evidence Bloomberg Law21:29 30-Apr-26

AZ, Amgen will pilot FDA's real-time clinical trial plan pharmaphorum13:09 29-Apr-26

Teva v. Lilly: Limiting Amgen’s Reach on Written Description and Enablement JD Supra20:26 28-Apr-26

Amgen to Report Q1 Earnings: Can It Keep the Beat Streak Alive? Zacks18:16 28-Apr-26

Did Amgen's Subsidiary Manipulate Data To Secure Tavneos Approval? RTT News16:31 28-Apr-26

FDA proposes to withdraw Amgen's drug for rare autoimmune diseases over effectiveness The Hindu Business Line05:34 28-Apr-26

Federal Circuit Clarifies Written Description and Enablement Standards for Method-of-Treatment Patent Claims Using a… JD Supra20:45 27-Apr-26

Amgen (AMGN) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks23:55 24-Apr-26

Well-Known Genus, Novel Method: A Post-Amgen Framework for Written Description & Enablement JD Supra21:57 24-Apr-26

Amgen Announces Webcast Of 2026 First Quarter Financial Results PR Newswire (Press Release)21:05 24-Apr-26

Amgen’s Chief Technology Officer Dr David Reese to retire European Pharmaceutical Review16:28 24-Apr-26

Biocon Launches Denosumab Biosimilars JD Supra17:18 23-Apr-26

Amgen Announces Retirement Of David M. Reese, Executive Vice President And Chief Technology… PR Newswire (Press Release)21:01 22-Apr-26

Biocon Launches Denosumab Biosimilars Bosaya™ / Aukelso™ in the United States JD Supra17:58 21-Apr-26

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks15:09 21-Apr-26

What to Expect From Amgen's Next Quarterly Earnings Report Barchart16:56 20-Apr-26

Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source South China Morning Post08:03 20-Apr-26

Amgen Korea pushes BiTE platform expansion into solid tumors with Imdelltra Korea Biomedical Review02:46 20-Apr-26

Will Amgen’s Subcutaneous Tepezza Success Reshape Viridian Therapeutics' (VRDN) Thyroid Eye Disease Narrative? Simply Wall St10:43 19-Apr-26

Is It Too Late To Consider Amgen (AMGN) After A 32% One-Year Share Price Rally? Simply Wall St06:49 19-Apr-26

Amgen (AMGN) Laps the Stock Market: Here's Why Zacks23:57 17-Apr-26

Amgen pipeline’s next growth cycle: replacing its old blockbusters Labiotech14:10 13-Apr-26

The biopharma senior associate whose career was fuelled by FUEL Silicon Republic12:31 12-Apr-26

Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again Zacks18:11 10-Apr-26

view more headlines

8 May 18:51

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.